Brilliant Yellow

CAS No. 3051-11-4

Brilliant Yellow( —— )

Catalog No. M37162 CAS No. 3051-11-4

Brilliant Yellow (Direct Yellow 4) is a potent and selective VGLUT inhibitor, a dye that is photodegradable.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Brilliant Yellow
  • Note
    Research use only, not for human use.
  • Brief Description
    Brilliant Yellow (Direct Yellow 4) is a potent and selective VGLUT inhibitor, a dye that is photodegradable.
  • Description
    Brilliant Yellow, a diazo-containing sulfonic aci, is also a potent VGLUT-specific inhibitor. Brilliant Yellow is membrane-impermeable. However, there are some Brilliant Yellow analogs with low cytotoxicity and cell penetration. Brilliant Yellow analogs work on glutamatergic transmission in hippocampal neurons.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    transporter
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3051-11-4
  • Formula Weight
    624.55
  • Molecular Formula
    C26H18N4Na2O8S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (16.01 mM; Ultrasonic (<60°C)
  • SMILES
    O=S([O-])(C1=CC(N=NC2=CC=C(C=C2)O)=CC=C1C=CC3=CC=C(C=C3S(=O)([O-])=O)N=NC4=CC=C(C=C4)O)=O.[Na+].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kehrl J, et al. Vesicular Glutamate Transporter Inhibitors: Structurally Modified Brilliant Yellow Analogs. Neurochem Res. 2017 Jun;42(6):1823-1832. ?
molnova catalog
related products
  • Oxepinac

    oxepinac is an effective and well-tolerated compound for the treatment of painful osteoarthritis. oxepinac has no teratogenic effect on mouse and rabbit fetuses in animal experiments.

  • α-ANF(1-28), human

    Atrial natriuretic factor (1-28) (human, porcine) exhibits blood pressure lowering activity by increasing sodium and urine excretion. Atrial natriuretic factor (1-28) (human, porcine) inhibits the release of pituitary adrenocorticotropic hormone (ACTH) and beta-endorphin through inhibition of pro-opiomelanocortin (POMC) expression. Atrial natriuretic factor (1-28) (human, porcine) increases cGMP levels in RMIC cells with an IC50 of 1.2 nM.

  • 5-Hydroxymethylcytos...

    5-Hydroxymethylcytosine is a naturally occurring component of mammalian genomic DNA and is thought to be the sixth base of DNA .